$21.9M in CY2024 Part D spend20K claims · 5K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Fondaparinux used for?
Fondaparinux prevents blood clots by inhibiting factor Xa, prescribed for atrial fibrillation and venous thromboembolism.
Is there a generic for Fondaparinux?
Yes. 16 ANDAs filed at FDA, 4 generic manufacturers currently shipping.
How much does my plan pay for Fondaparinux?
Across 329 Part D plans, Fondaparinux averages $34.71/unit (NADAC). Lowest available: $12.77/unit. Highest in distribution: $55.31/unit.
Is Fondaparinux on the FDA shortage list?
Fondaparinux has been discontinued by its manufacturer(s).
8 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.